Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Oncoimmunology|June 15, 2018
The possibility of cancer immune editing in gliomas. A critical reviewVíctor A Arrieta, Bernardo Cacho-Díaz, Junfei Zhao, et al.
International Journal of Cancer|February 18, 2022
Repurposing autophagy regulators in brain tumorsEdgar Petrosyan, Jawad Fares, Alex Cordero, et al.
International Journal of Molecular Sciences|December 24, 2021
The Eclectic Nature of Glioma-Infiltrating Macrophages and MicrogliaVíctor A Arrieta, Hinda Najem, Edgar Petrosyan, et al.
The Journal of Clinical Investigation|January 17, 2023
Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatmentVíctor A Arrieta, Crismita Dmello, Daniel J McGrail, et al.
Frontiers in Immunology|July 5, 2022
Myeloid Cell Classification and Therapeutic Opportunities Within the Glioblastoma Tumor Microenvironment in the Single Cell-Omics EraCollin J Larkin, Víctor A Arrieta, Hinda Najem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2023
ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-guided AnalysisVíctor A Arrieta, Johnny Duerinck, Kirsten B Burdett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 21, 2020
CD8<sup>+</sup> T-cell-Mediated Immunoediting Influences Genomic Evolution and Immune Evasion in Murine GliomasJoshua R Kane, Junfei Zhao, Takashi Tsujiuchi, et al.
The Lancet. Oncology|May 4, 2023
Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trialAdam M Sonabend, Andrew Gould, Christina Amidei, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
MAPK/ERK signaling in gliomas modulates interferon responses, T cell recruitment, microglia phenotype, and immune checkpoint blockade efficacyKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Nature Communications|June 25, 2026
Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responsesKwang-Soo Kim, Junyi Zhang, Víctor A Arrieta, et al.
Pageof 2